Rolf-Markus Szeimies (R M Szeimies, R-M Szeimies)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Randomized Controlled Trial

Decision Making

Atopic Dermatitis

Photodynamic Therapy

Top Venues

Dermatology and therapy

The British journal of dermatology

Journal of the European Academy of Dermatology and Venereology : JEADV

JMIR research protocols

This page only lists publications with an associated author ORCID identifier.

Publications

Rolf-Markus Szeimies, Claas Ulrich, Carla Ferrándiz-Pulido, Gunther F L Hofbauer, John Thomas Lear, Celeste Lebbé, Stefano Piaserico, Merete Hædersdal
The "Personalising Actinic Keratosis Treatment for Immunocompromised Patients" (IM-PAKT) Project: An Expert Panel Opinion. Dermatology and therapy 14 (7) (2024)
Rolf-Markus Szeimies, Claas Ulrich, Carla Ferrándiz-Pulido, Gunther F L Hofbauer, John Thomas Lear, Celeste Lebbé, Stefano Piaserico, Merete Hædersdal
The "Personalising Actinic Keratosis Treatment for Immunocompromised Patients" (IM-PAKT) Project: An Expert Panel Opinion. Dermatology and therapy 14 (7) (2024)
Rolf-Markus Szeimies, Claas Ulrich, Carla Ferrándiz-Pulido, Gunther F L Hofbauer, John Thomas Lear, Celeste Lebbé, Stefano Piaserico, Merete Hædersdal
The "Personalising Actinic Keratosis Treatment for Immunocompromised Patients" (IM-PAKT) Project: An Expert Panel Opinion. Dermatology and therapy 14 (7) (2024)
Rolf-Markus Szeimies, Claas Ulrich, Carla Ferrándiz-Pulido, Gunther F L Hofbauer, John Thomas Lear, Celeste Lebbé, Stefano Piaserico, Merete Hædersdal
The "Personalising Actinic Keratosis Treatment for Immunocompromised Patients" (IM-PAKT) Project: An Expert Panel Opinion. Dermatology and therapy (2024)
Rolf-Markus Szeimies, Claas Ulrich, Carla Ferrándiz-Pulido, Gunther F L Hofbauer, John Thomas Lear, Celeste Lebbé, Stefano Piaserico, Merete Hædersdal
The "Personalising Actinic Keratosis Treatment for Immunocompromised Patients" (IM-PAKT) Project: An Expert Panel Opinion. Dermatology and therapy 14 (7) (2024)
Christoph Abels, Michael Soeberdt, A Kilic, H Reich, U Knie, C Jourdan, K Schramm, S Heimstaedt-Muskett, Clarissa Masur, Rolf-Markus Szeimies
A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial. The British journal of dermatology 185 (2) (2021)
C A Morton, Rolf-Markus Szeimies, Nicole Basset-Seguin, P Calzavara-Pinton, Y Gilaberte, M Haedersdal, G F L Hofbauer, R E Hunger, S Karrer, S Piaserico, C Ulrich, A-M Wennberg, L R Braathen
European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications - actinic keratoses, Bowen's disease and basal cell carcinomas. Journal of the European Academy of Dermatology and Venereology : JEADV 33 (12) (2020)
C A Morton, Rolf-Markus Szeimies, Nicole Basset-Seguin, P G Calzavara-Pinton, Y Gilaberte, M Haedersdal, G F L Hofbauer, R E Hunger, S Karrer, S Piaserico, C Ulrich, A-M Wennberg, L R Braathen
European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 2: emerging indications - field cancerization, photorejuvenation and inflammatory/infective dermatoses. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (1) (2019)
Serge R Mordon, Anne Sophie Vignion-Dewalle, Henry Abi Rached, Elise Thecua, Fabienne Lecomte, Claire Vicentini, Pascal Deleporte, Hélène Béhal, D Kerob, Theresa Hommel, Alain Duhamel, Rolf-Markus Szeimies, Laurent Mortier
The conventional protocol vs. a protocol including illumination with a fabric-based biophotonic device (the Phosistos protocol) in photodynamic therapy for actinic keratosis: a randomized, controlled, noninferiority clinical study. The British journal of dermatology 182 (1) (2019)
Anne Sophie Vignion-Dewalle, Henry Abi Rached, Elise Thecua, Fabienne Lecomte, Pascal Deleporte, Hélène Béhal, Theresa Hommel, Alain Duhamel, Rolf-Markus Szeimies, Laurent Mortier, Serge R Mordon
A New Light-Emitting, Fabric-Based Device for Photodynamic Therapy of Actinic Keratosis: Protocol for a Randomized, Controlled, Multicenter, Intra-Individual, Phase II Noninferiority Study (the Phosistos Study). JMIR research protocols 8 (4) (2019)
Rolf-Markus Szeimies, Piergiacomo Calzavara-Pinton
A randomized, double-blind trial comparing 5-aminolaevulinic acid nanoemulsion with methyl 5-aminolaevulinate in daylight photodynamic therapy for actinic keratosis. The British journal of dermatology 181 (1) (2019)